HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation. (Q37949185)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22024621%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22024621%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22024621%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Melanie R Shakespear

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22024621%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

David P. Fairlie

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22024621%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Nabilah A Kamal

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22024621%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

25 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22024621%20AND%20SRC:MED&resulttype=core&format=json

Immunology & Cell Biology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22024621%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22024621%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22024621%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

14-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22024621%20AND%20SRC:MED&resulttype=core&format=json

Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Anticancer activities of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

The clinical development of histone deacetylase inhibitors as targeted anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase inhibitors in inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylases as regulators of inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Finally, how histone deacetylase inhibitors disrupt mitosis!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase inhibitors specifically kill nonproliferating tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Colony-stimulating factors in inflammation and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Inhibition of histone deacetylase suppresses osteoclastogenesis and bone destruction by inducing IFN-beta production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

HDAC3 and HDAC7 have opposite effects on osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Loss of PU.1 expression following inhibition of histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Macrophages require constitutive NF-kappaB activation to maintain A1 expression and mitochondrial homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Identification of novel isoform-selective inhibitors within class I histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase inhibitors decrease the antigen presenting activity of murine bone marrow derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Romidepsin: in the treatment of T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase inhibitors induce apoptosis in human eosinophils and neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Trichostatin A attenuates airway inflammation in mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase 7 functions as a key regulator of genes involved in both positive and negative selection of thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase 7 regulates cell survival and TCR signaling in CD4/CD8 double-positive thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Effects of histone deacetylase inhibitor SAHA on effector and FOXP3+regulatory T cells in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Deacetylase inhibition promotes the generation and function of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Conditional deletion of histone deacetylase 1 in T cells leads to enhanced airway inflammation and increased Th2 cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Lysine acetylation targets protein complexes and co-regulates major cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

7 January 2021

Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

7 January 2021

Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

7 January 2021

Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: a comparative quantitative morphometric study

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

7 January 2021

The short chain fatty acid sodium butyrate regulates the induction of CD1a in developing dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

7 January 2021

Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.88

7 January 2021

Identifiers

DOI

10.1038/ICB.2011.88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22024621%20AND%20SRC:MED&resulttype=core&format=json

release_q7rjtk53ybdepcveprviqcgbg4

15 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q7rjtk53ybdepcveprviqcgbg4

24 November 2022

mapped directly with Wikidata item

1 reference